Explore the latest in pancreatic disease, including advances in diagnosis and management of pancreatitis and pancreatic cancer.
This cohort study evaluates the association between surgical resection and survival for patients with small, localized nonfunctional pancreatic neuroendocrine tumors.
This cohort study of data from the National Cancer Database on patients with pancreatic adenocarcinoma who received neoadjuvant chemotherapy compares overall survival between those who received adjuvant chemotherapy and those who did not.
This randomized clinical trial investigates whether NPC-1C, an antibody directed against MUC5AC, might increase the efficacy of second-line gemcitabine and nab-paclitaxel in patients with advanced pancreatic ductal adenocarcinoma (PDAC).
This narrative review describes the most common treatment strategies in the step-up approach to managing necrotizing pancreatitis, including a discussion of common complications and associated issues.
This cohort study evaluates survival outcomes with adjuvant chemotherapy for patients with node-negative disease after neoadjuvant therapy and surgical resection for pancreatic cancer.
This comparative effectiveness study evaluates long-term survival after minimally invasive and standard open surgery with curative intent among patients with pancreatic adenocarcinoma.
This case-control study sought to confirm the exploratory finding of an association between polycystic ovary syndrome and risk of pancreatic cancer.
This randomized crossover clinical trial compares bihormonal artificial pancreas treatment with current diabetes care in patients with total pancreatectomy.
This cohort study investigates the association of newborn screening for cystic fibrosis with child outcomes up to age 10 years in the US.
This cohort study evaluates postoperative adherence to venous thromboembolism prophylaxis guidelines among US adults with pancreatic cancer using a national population sample drawn from Surveillance, Epidemiology, and End Results–Medicare data.
This narrative review provides an overview of the current guidelines for the surveillance and management of pancreatic cystic lesions.
This single-center prognostic study of biopsy specimens from treatment-naive patients with pancreatic ductal adenocarcinoma assesses the association of aberrant gene expression as well as expression of matrix metalloproteinase 7 with pathologic response to preresection neoadjuvant therapy.
A 47-year-old woman with a history of metastatic neuroendocrine carcinoid tumor status in remission after liver transplant was hospitalized for workup of a new pancreatic mass concerning for recurrence. Examination revealed restriction of extraocular movements in all directions of gaze, diffuse punctate epithelial erosions, and mechanical lower lid entropion secondary to severe chemosis in both eyes as well as bilateral and symmetric tendon-sparing extraocular muscle enlargement of all extraocular muscles with nodular heterogenous enhancement. What would you do next?
This cohort study evaluates the association of dynamic therapy with oncologic outcomes among patients with surgically resected pancreatic cancer.
This nonrandomized clinical trial evaluates the response rate to treatment with a combination of bevacizumab and atezolizumab in patients with advanced neuroendocrine tumors.
Customize your JAMA Network experience by selecting one or more topics from the list below.